GenapSys has developed a novel electrical-based platform capable of accurately detecting single base incorporations. The semiconductor chip-based detection modality allows the system to be compact, scalable, and affordable.
The GenapSys platform has been successfully demonstrated in a range of
applications that include targeted sequencing to elucidate
both germline and somatic mutations, as well as sequencing a range of small genomes.